Suppr超能文献

纤溶酶原激活物抑制剂-1 4G/5G多态性表现为复发性缺血性卒中:微血栓阵雨

Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Presenting as Recurrent Ischemic Stroke: The Microthrombi Shower.

作者信息

Dayco John, Ataya Taha, Tidwell Chad, Awadelkarim Abdalaziz M, Alhusain Rashid, Ali Mohammed, Halboni Adnan, Dawdy John, Lieberman Randy

机构信息

Internal Medicine, Wayne State University Detroit Medical Center, Detroit, USA.

出版信息

Cureus. 2022 Apr 4;14(4):e23828. doi: 10.7759/cureus.23828. eCollection 2022 Apr.

Abstract

Certain clinical scenarios should alert a physician to take a deeper look into causative pathological processes. This was evident in the case of a 41-year-old man who presented for recurrent micro thromboembolic strokes, which is atypical for the patient's age. Our desire to explain the pathological process led to the rare finding of a plasminogen activator inhibitor-1 polymorphism, which has been associated with an increased risk of cerebrovascular thrombosis. A defect in this pathway leads to the inhibition of the tissue plasminogen activator protein. This genetic polymorphism has relatively been unexplored in recent medical literature, and we are hoping that our case may inspire future research that could help potential targets of risk factor stratifications as well as the development of novel pharmacological options.

摘要

某些临床情况应提醒医生更深入地研究致病的病理过程。这在一名41岁男性患者的病例中很明显,该患者因反复发生微血栓栓塞性中风前来就诊,这在其这个年龄并不常见。我们想要解释病理过程的愿望导致了一个罕见的发现,即纤溶酶原激活物抑制剂-1多态性,它与脑血管血栓形成风险增加有关。该途径中的缺陷会导致组织纤溶酶原激活蛋白受到抑制。这种基因多态性在最近的医学文献中相对未被探索,我们希望我们的病例能激发未来的研究,这可能有助于确定风险因素分层的潜在靶点以及开发新的药物选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ec/9072283/3459c7c0341e/cureus-0014-00000023828-i01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验